Kate is passionate about applying innovative approaches to solve the greatest challenges in life sciences. Since joining SSI in 2011, she has worked with industry leaders to address some of the highest areas of unmet need for patients, including advancing novel modalities (gene therapy, digital diagnostics) focused in rare disease.
Kate has over 13 years of experience providing strategic and operational solutions across the Medical Office, with functional experience in Medical Affairs, Clinical Development, Clinical Operations, HEOR & Real World Evidence, Safety, Quality, and Corporate Program Management. She specializes in helping business leaders define and operationalize their corporate, clinical, medical, and organizational strategies to drive value for client organizations, investors, and ultimately, for patients.
A sampling of Kate’s work includes:
Kate also supports various SSI corporate initiatives, including SSI’s investment fund. Prior to SSI, Kate was a member of Deloitte’s Strategy & Operations practice, where she delivered M&A/ integration, financial management, and human capital solutions. She received her B.A. from Penn State University.